Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? The REACT study protocol.

International journal of chronic obstructive pulmonary disease

Volumn 7, Issue , 2012, Pages 375-382

  Calverley, Peter M A ^a   Martinez, Fernando J ^b   Fabbri, Leonardo M ^b   Goehring, Udo Michael ^b   Rabe, Klaus F ^b  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPYRIDINE DERIVATIVE; BENZAMIDE DERIVATIVE; BRONCHODILATING AGENT; CORTICOSTEROID; CYCLOPROPANE DERIVATIVE; PHOSPHODIESTERASE IV INHIBITOR; ROFLUMILAST;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; HUMAN; MALE; METHODOLOGY; MULTICENTER STUDY; PATHOPHYSIOLOGY; POISSON DISTRIBUTION; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; AMINOPYRIDINES; BENZAMIDES; BRONCHODILATOR AGENTS; CYCLOPROPANES; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PHOSPHODIESTERASE 4 INHIBITORS; POISSON DISTRIBUTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY THERAPY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84871698675     PISSN: None     EISSN: 11782005     Source Type: Journal    
DOI: None     Document Type: Article

References (0)